| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bab34457c0c62aadf06ac0280240a61 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 |
| filingDate |
2021-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_901141bc3000220a7071c4f5b720d72f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_128956a783c03244b828e90e7da9a5f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0153a4a3058f8e30a3287455b459a7d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79b7c282ea3641e08226bba007aab35b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bfe6db8409cdb8cc357cb1db52a6222 |
| publicationDate |
2021-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2021202942-A1 |
| titleOfInvention |
A maleate salt of the free base of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide, pharmaceutical formulations, methods of manufacture and uses thereof for the treatment of herpes viruses |
| abstract |
The present invention relates to the field of anti-viral active agents, particularly to salts, more nparticularly to a maleate salt of the free base of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2n5 yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide, to pharmaceutical formulations thereof as nwell as to methods for the production of these salts. The present invention also relates to the nuse of theses salts and of respective pharmaceutical formulations thereof in methods of ntreatment and/or prevention of human herpes simplex virus infections, particulary infections ncaused by HSV-1 and HSV-2. |
| priorityDate |
2016-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |